Institutional Ownership Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 266,400 shares, which have been reported (via 13F filing form) to have a value of $58,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
160,000
shares
|
$35,200
0.28% of portfolio
|
Q4 2021
New holding
|
|
|
Clear Street LLC
|
Feb 14, 2025 Q4 2024 |
65,659
shares
|
$14,444
0.0% of portfolio
|
Q4 2024
Reduced 0.15%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
22,711
shares
|
$4,996
0.0% of portfolio
|
Q4 2024
Reduced 10.14%
|
|
|
Warberg Asset Management LLC
Winnetka, IL |
Feb 13, 2025 Q4 2024 |
17,936
shares
|
$3,945
0.06% of portfolio
|
Q4 2024
Reduced 11.21%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
94
shares
|
$20
0.0% of portfolio
|
Q4 2024
Reduced 53.0%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|